Icon

QELBREE (nda211964)- (EQ 100MG BASE,EQ 150MG BASE,EQ 200MG BASE)

VILOXAZINE HYDROCHLORIDE SUPERNUS PHARMS
EQ 100MG BASE,EQ 150MG BASE,EQ 200MG BASE
No No
2033-Feb-07 2026-Apr-02
None None
None No
Qelbree is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older.
0 0 0
Total Other Developers 9
Drugs with Suitability No
EQ 100MG BASE ** ** Up - -
EQ 150MG BASE ** ** Up - -
EQ 200MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.